Results of Randomized Double Blind Phase III trial of FDC of Remogliflozin Etabonate and Teneligliptin in T2DM patients

被引：0
|
作者：
Balamurgan, R. [1 ]
Mohan, B. [2 ]
Kodgule, R. [3 ]
Tandon, M. [3 ]
Pendse, A. [4 ]
Khaladkar, K. [5 ]
Sharath, R. [5 ]
Katare, S. [5 ]
Suryawanshi, S. [5 ]
Barkate, H. [5 ]
机构：
[1] Kovai Diabet Specialty Ctr & Hosp, Diabetol, Coimbatore, Tamil Nadu, India
[2] Brij Med Ctr Pvt Ltd, Diabetol, Kanpur, Uttar Pradesh, India
[3] Glenmark Pharmaceut Ltd, Dept Clin Dev, Mumbai, Maharashtra, India
[4] Glenmark Pharmaceut Ltd, Dept Clin Operat, Mumbai, Maharashtra, India
[5] Glenmark Pharmaceut Ltd, Dept Global Med Affairs, Mumbai, Maharashtra, India
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2022年 / 186卷
关键词：
D O I：
10.1016/j.diabres.2022.109517
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF21-0338
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Multicenter, Randomized, Double-Blind Study to Compare the Safety and Efficacy of Sitagliptin/Metformin Fixed-Dose Combination to Glimepiride in Patients with T2DM
    Kim, Sang Soo
    Park, Jeong Hyun
    Lee, Kwang Jae
    Chung, Sung Chang
    Kim, Young Il
    Lee, Young Sil
    Lee, Sang Jin
    Kim, In Joo
    DIABETES, 2015, 64 : A654 - A655
  • [32] ARCON FOR T2-T4 LARYNGEAL CANCER: RESULTS OF A PHASE III RANDOMIZED TRIAL
    Kaanders, J.
    Terhaard, C.
    Doornaert, I.
    Bij, H. P.
    van den Ende, P.
    Chin, A.
    Span, I.
    de Bree, R.
    Takes, R.
    Janssens, G. O.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S5 - S5
  • [33] A randomized, double-blind trial comparing a new, rapid onset and short-duration insulin secretagogue, mitiglinide, toAcarbose for the treatment of elderly patients with type 2 diabetes mellitus (T2DM)
    Sinclair, Alan J.
    Whisnant, John K.
    DIABETES, 2007, 56 : A563 - A563
  • [34] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
    Ting-Ting Yin
    Yan Bi
    Ping Li
    Shan-Mei Shen
    Xiao-Lu Xiong
    Li-Jun Gao
    Can Jiang
    Yan Wang
    Wen-Huan Feng
    Da-Long Zhu
    Diabetes Therapy, 2018, 9 : 1253 - 1267
  • [35] FEASibility testing a randomized controlled trial of an exercise program to improve cognition for T2DM patients (the FEAST trial): A study protocol
    Liu, Tingting
    Hettish, Lindsey
    Lo, Wen-Juo
    Gray, Michelle
    Li, Changwei
    RESEARCH IN NURSING & HEALTH, 2021, 44 (05) : 746 - 757
  • [36] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
    Yin, Ting-Ting
    Bi, Yan
    Li, Ping
    Shen, Shan-Mei
    Xiong, Xiao-Lu
    Gao, Li-Jun
    Jiang, Can
    Wang, Yan
    Feng, Wen-Huan
    Zhu, Da-Long
    DIABETES THERAPY, 2018, 9 (03) : 1253 - 1267
  • [37] Prospect: A randomized, double-blind, phase III efficacy trial of PROSTVAC.
    Bandman, Olga
    Delcayre, Alain
    Laus, Reiner
    Godfrey, Wayne Russell
    Kantoff, Philip W.
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Masato Murakami
    Kenichi Osada
    Hiromichi Mizuno
    Toshimitsu Ochiai
    Levent Alev
    Kusuki Nishioka
    Arthritis Research & Therapy, 17
  • [39] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Murakami, Masato
    Osada, Kenichi
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Alev, Levent
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [40] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
12345